Title: Point of Care Testing for Infectious Diseases Market: Latest Trends, Demand & Analysis 2020-2025
1Point of Care Testing for Infectious Diseases
Market
- Size 2019, By Infection Type (HIV, Clostridium
difficile, HBV, Pneumonia or Streptococcus
associated infections, RSV, HPV, Influenza/Flu,
HCV, MRSA, TB, HSV and Others), By Usage Area
(Hospitals, Clinica, Clinical Laboratories,
Assisted Living Facilities, Others), By Region
and Forecast 2019 to 2025
Single Use License US 4400
Request Sample
2Point of Care Testing for Infectious Diseases
Market Size and Share-Global Forecast to 2025
- The global point of care diagnostics for
infectious diseases market is anticipated to
reach a value of USD 2.2 billion by 2025, growing
at a CAGR of 9.1 during the forecast period from
2019 to 2025. Recent pandemic crisis and the
consistent growth in incidence of infections,
along with the growing trend of consumer centric
services to patients contribute to the growth of
this market. Furthermore, appropriate deployment
of point of care testing at healthcare and
inpatient settings also allow in cost containment
in the long run to hospital as it efficiently
assists in reducing lead time for diagnosis,
patient stay and ultimately healthcare cost. - Additionally, growing prevalence in pediatric and
geriatric populations along with increasing pool
of this population sets are also attributes to
the increased demand for point of care diagnostic
tools for infections. Further innovation and
technological advancements will open up new
opportunistic avenues for market development. - Browse Complete Research Report _at_
https//www.adroitmarketresearch.com/industry-repo
rts/point-of-care-testing-for-infectious-diseases-
market
3Point of Care Testing for Infectious Diseases
Market Size and Share-Global Forecast to 2025
- Adroit Market Research report on global point of
care testing for infectious diseases market gives
a holistic view of the market from 2015 to 2025,
which includes factors such as market drivers,
restraints, opportunities and challenges. The
market has been studied for historic years from
2015 to 2017, with the base year of estimation as
2018 and forecast from 2019 to 2025. The report
covers the current status and future traits of
the market at global as well as country level. In
addition, the study also assesses the market
based on Porter's five forces analysis and
positions the key players based on their product
portfolio, geographic footprint, strategic
initiatives and overall revenue. Prominent
players operating in the global point of care
testing for infectious diseases market have been
studied in detail. - Point of care testing refers to diagnostic
procedures performed at patient site for
providing swift test results. Diagnosis of
infections such as tuberculosis, influenza, STDs,
and HIV along with some tropical diseases has
become a convenient affair through POC testing
and thus has also resulted in disease containment
and public health management to a considerable
extent. These tests enable prompt access to care
while reducing the risk of disease transmission.
Furthermore, POC testing also assists in
efficient disease management in remote areas. The
latest developments in the nature of diagnostic
technologies and delivery of healthcare services
have led to significant growth in demand for
point of care tests for infection diagnosis in
public healthcare services.
4Point of Care Testing for Infectious Diseases
Market Size and Share-Global Forecast to 2025
- Geographically, North America dominates the
global point of care infectious disease
diagnostics market. High awareness, better
availability of POC kits, and high incidence of
infections in the region. Asia Pacific, despite
its large population base and high incidence of
infectious diseases, especially those like
tropical diseases, has not yet reached the market
status as North America. However, the growth of
Asia Pacific market has been picking pace and is
anticipated to witness a continued trend through
the forecast period. China and Indian markets
will spearhead the growth in Asia Pacific,
through attributes such as growing awareness,
rapid development of healthcare infrastructure,
improving purchasing power and growing funding of
domestic governments. - Introduction of novel point of care testing
technologies such as lab on chip and
microfluidics will open new market development
opportunities in the future. Additionally,
changes in regulatory environment in terms of
speeding up the process of approval will further
render to the market growth. Major companies
operating in the point of care testing for
infectious diseases market are Thermo Fisher
Scientific Inc., Alere Inc., Chembio Diagnostic
Systems Inc., Trinity Biotech plc, Quest
Diagnostics Inc., F. Hoffmann-La Roche Ltd.,
bioMérieux SA, Bio-Rad Labs Inc., Cardinal
Health, BD Company, Ortho-Clinical
Diagnostics and others. - Purchase This Report _at_ https//www.adroitmarketres
earch.com/researchreport/purchase/1580
5Point of Care Testing for Infectious Diseases
Market Size and Share-Global Forecast to 2025
- Key Segments of the Global Point of Care Testing
for Infectious Diseases Market - Infection Overview, 2015-2025 (USD Million)
- HIV
- Clostridium difficile
- HBV
- Pneumonia or Streptococcus associated infections
- Respiratory syncytial virus (RSV)
- HPV
- Influenza/Flu
- HCV
- MRSA
- TB and drug-resistant TB
- HSV (Herpes Simplex Virus)
- Others
6Point of Care Testing for Infectious Diseases
Market Size and Share-Global Forecast to 2025
- Usage Area Overview, 2015-2025 (USD Million)
- Hospitals
- Clinics
- Home Care
- Clinical Laboratories
- Assisted Living Facilities
- Others
7Point of Care Testing for Infectious Diseases
Size and Share-Global Forecast to 2025
- Regional Overview, 2015-2025 (USD Million)
- North America
- U.S.
- Canada
- Europe
- Germany
- United Kingdom
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East Africa
8About Us
- Adroit Market Research is an India-based business
analytics and consulting company. Our target
audience is a wide range of corporations,
manufacturing companies, product/technology
development institutions and industry
associations that require understanding of a
markets size, key trends, participants and
future outlook of an industry. We intend to
become our clients knowledge partner and provide
them with valuable market insights to help create
opportunities that increase their revenues. We
follow a code Explore, Learn and Transform. At
our core, we are curious people who love to
identify and understand industry patterns, create
an insightful study around our findings and churn
out money-making roadmaps. Our analysts have
tracked high growth markets in chemicals
materials, healthcare pharmaceuticals,
semiconductor electronics, energy power, food
retail, consumer goods, technology, and
machinery equipment sectors across the world to
identify new opportunities, potential customers,
prepare go-to-market (GTM) strategies, identify
segments for revenue growth for companies, and
many more.
- US Headquarters3131 McKinney Ave Ste 600
Dallas, TX 75204 ,U.S.A
- Phone 1 (214) 884-6068
- Email sales_at_adroitmarketresearch.com